
1. Parasitol Res. 2021 Dec;120(12):4037-4047. doi: 10.1007/s00436-021-07342-1. Epub 
2021 Oct 19.

ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and
prognostic marker for visceral leishmaniasis and human immunodeficiency virus
coinfection.

Galvani NC(1), Machado AS(1), Lage DP(1), Freitas CS(1), Vale DL(1), de Oliveira 
D(2), Ludolf F(1), Ramos FF(1), Fernandes BB(2), Luiz GP(2), Mendonça DVC(1),
Oliveira-da-Silva JA(1), Reis TAR(1), Tavares GSV(1), Chaves AT(1), Guimarães
NS(1), Tupinambás U(1), Cota GF(3), Humbert MV(4), Martins VT(1), Christodoulides
M(4), Coelho EAF(5)(6), Machado-de-Ávila RA(2).

Author information: 
(1)Laboratório de Pesquisa do Programa de Pós-Graduação em Ciências da Saúde:
Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de 
Minas Gerais, Avenida Prof. Alfredo Balena, 190, Belo Horizonte, Minas Gerais,
30130-100, Brazil.
(2)Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul
Catarinense, Criciúma, Santa Catarina, 88806-000, Brazil.
(3)Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, FIOCRUZ, Belo
Horizonte, Minas Gerais, Brazil.
(4)Neisseria Research Group, Molecular Microbiology, School of Clinical and
Experimental Sciences, Faculty of Medicine, University of Southampton,
Southampton General Hospital, Southampton, SO16 6YD, England, UK.
(5)Laboratório de Pesquisa do Programa de Pós-Graduação em Ciências da Saúde:
Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de 
Minas Gerais, Avenida Prof. Alfredo Balena, 190, Belo Horizonte, Minas Gerais,
30130-100, Brazil. eduardoferrazcoelho@yahoo.com.br.
(6)Departamento de Patologia Clínica, COLTEC, Universidade Federal de Minas
Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
eduardoferrazcoelho@yahoo.com.br.

Visceral leishmaniasis (VL) is a neglected tropical disease of global importance 
caused by parasites of the genus Leishmania, and coinfection with human
immunodeficiency virus (HIV) is common in countries where both diseases are
endemic. In particular, widely used immunological tests for VL diagnosis have
impaired sensitivity (Se) and specificity (Sp) in VL/HIV coinfected patients and 
there is also cross-reactivity with other endemic diseases, e.g., Chagas disease,
malaria, and tuberculosis. To develop new antigens to improve the diagnosis of VL
and VL/HIV coinfection, we predicted eight specific B-cell epitopes of four
Leishmania infantum antigens and constructed a recombinant polypeptide chimera
antigen called ChimLeish. A serological panel of 195 serum samples was used to
compare the diagnostic capabilities of ChimLeish alongside the individual
synthetic peptides. ChimLeish reacted with sera from all VL and VL/HIV coinfected
patients [Se = 100%; Sp = 100%; area under the curve (AUC) = 1.0]. Peptides
showed lower reactivities (Se = 76.8 to 99.2%; Sp = 67.1 to 95.7%; AUC between
0.87 and 0.98) as did a L. infantum antigenic preparation used as an antigen
control (Se = 56.8%; Sp = 69.5%: AUC = 0.45). Notably, ChimLeish demonstrated a
significant reduction (p < 0.05) of anti-ChimLeish antibodies after treatment and
cure of a small number of patients. Although only a limited serological panel was
tested, preliminary data suggest that ChimLeish should be evaluated in larger
sample studies for the diagnosis of VL and VL/HIV coinfection.

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany,
part of Springer Nature.

DOI: 10.1007/s00436-021-07342-1 
PMCID: PMC8523347
PMID: 34664113  [Indexed for MEDLINE]

